Hypertension (HTN) as a potential biomarker of efficacy in pazopanib-treated patients with advanced non-adipocytic soft tissue sarcoma. A retrospective study based on European Organisation for Research and Treatment of Cancer (EORTC) 62043 and 62072 trials

Publication | Closed Access

DOI

Citations

References

2015

Year

Florence Duffaud, Stefan Sleijfer, Saskia Litière, Isabelle Ray‐Coquard, Axel Le Cesne, Zsuzsa Pápai, Ian Judson, Patrick Schöffski, Sant P. Chawla, R. Dewji,

European Journal of Cancer

Retrospective StudyHypertensionSurgical OncologyOncologyAntihypertensive TherapyPazopanib-treated PatientsPotential BiomarkerCancer TreatmentMedicineRadiation OncologyCancer Research